| # | Drug | Count |
|---|---|---|
| 0 | DASATINIB | 30 |
| 1 | PONATINIB HYDROCHLORIDE | 26 |
| 2 | METHOTREXATE SODIUM | 24 |
| 3 | PREDNISONE | 24 |
| 4 | METHOTREXATE | 22 |
| 5 | CYTARABINE | 20 |
| 6 | CYCLOPHOSPHAMIDE | 17 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 9 | IMATINIB | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PONATINIB HYDROCHLORIDE | 26 | 0.0050 |
| 1 | DASATINIB | 30 | 0.0032 |
| 2 | INOTUZUMAB OZOGAMICIN | 6 | 0.0020 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 2 | 0.0012 |
| 4 | ASCIMINIB | 4 | 0.0011 |
| 5 | BLINATUMOMAB | 8 | 0.0007 |
| 6 | AMIKACIN SULFATE | 1 | 0.0006 |
| 7 | MITOXANTRONE HYDROCHLORIDE | 3 | 0.0005 |
| 8 | RASBURICASE | 1 | 0.0004 |
| 9 | CYTARABINE | 20 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 6 | 0.0020 |
| 1 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 2 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | BCL-2 Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Azole Antifungal [EPC] | 15 | 0.0001 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 21 | 0.0001 |
| 8 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 17 | 0.0001 |